SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-21-256646
Filing Date
2021-08-26
Accepted
2021-08-25 21:51:09
Documents
3
Period of Report
2021-08-25

Document Format Files

Seq Description Document Type Size
1 6-K d610126d6k.htm 6-K 9609
2 EX-99.1 d610126dex991.htm EX-99.1 100808
3 GRAPHIC g610126dsp004.jpg GRAPHIC 4443
  Complete submission text file 0001193125-21-256646.txt   117653
Mailing Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900
Business Address TUBORG BOULEVARD 12 HELLERUP G7 DK-2900 45 70 22 22 44
Ascendis Pharma A/S (Filer) CIK: 0001612042 (see all company filings)

IRS No.: 000000000 | State of Incorp.: G7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36815 | Film No.: 211208633
SIC: 2834 Pharmaceutical Preparations